Choline transport and acetylcholine synthesis pathway

The choline transport and acetylcholine synthesis pathway is a fundamental metabolic sequence in cholinergic neurons that governs the production and storage of the neurotransmitter acetylcholine (ACh) (StatPearls: Physiology, Acetylcholine). This pathway involves the high-affinity uptake of choline from the synaptic cleft by the choline transporter (CHT1/SLC5A7), which serves as the rate-limiting step for synthesis (UniProt Q9GZV3). Once inside the cytoplasm, the enzyme choline acetyltransferase (ChAT) facilitates the reaction between choline and acetyl-CoA to produce ACh (UniProt P28329). The neurotransmitter is then sequestered into synaptic vesicles by the vesicular acetylcholine transporter (VAChT/SLC18A3) for regulated release (UniProt Q16572). Deficits in this pathway, particularly reduced ChAT activity and CHT1 function, are strongly associated with the cognitive decline observed in Alzheimer's disease and other dementias (PubMed: PMC3603430). Pharmacological interventions typically aim to preserve ACh levels by inhibiting its breakdown or, experimentally, by enhancing the efficiency of choline transport and synthesis (PubChem: Donepezil). Research into this pathway also extends to neuromuscular disorders like Myasthenia Gravis, where synaptic transmission is compromised (NIH: Myasthenia Gravis). Targeting specific components like CHT1 is considered a potential strategy for pro-cognitive therapy (PubMed: 21496569).

Other names

Cholinergic biosynthetic pathwayAcetylcholine synthesis and transport systemCholine-acetylcholine cycleACh synthesis pathway

The pathway is modulated through the inhibition of acetylcholine degradation by acetylcholinesterase inhibitors, the blockade of high-affinity choline uptake by hemicholinium-3, the inhibition of vesicular transport by vesamicol, or the enhancement of choline transporter activity by compounds like coluracetam.